|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
37,090,000 |
Market
Cap: |
8.35(M) |
Last
Volume: |
1,764,528 |
Avg
Vol: |
1,748,009 |
52
Week Range: |
$0.2136 - $1.17 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Viracta Therapeutics is a precision oncology company focused on the development of medicines targeting virus-associated malignancies. Co.'s main program is focused on cancers associated with the Epstein-Barr virus (EBV). Co.'s main product candidate is an all-oral combination therapy of its investigational drug, nanatinostat and the antiviral agent valganciclovir (collectively referred to as Nana-val). Nana-val is being investigated in clinical trials, including NAVAL-1, a trial for the treatment of multiple subtypes of relapsed/refractory EBV-positive (EBV+) lymphoma, as well as a trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
100,000 |
100,000 |
Total Buy Value |
$0 |
$0 |
$49,361 |
$49,361 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
0 |
0 |
7,125 |
25,675 |
Total Sell Value |
$0 |
$0 |
$4,353 |
$39,641 |
Total People Sold |
0 |
0 |
1 |
2 |
Total Sell Transactions |
0 |
0 |
2 |
8 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Misfeldt Dayton |
Director |
|
2017-10-27 |
4 |
B |
$2.00 |
$800,000 |
I/I |
400,000 |
30,456 |
2.1 |
- |
|
Parker Geoffrey M. |
Director |
|
2016-12-09 |
4/A |
B |
$3.90 |
$2,318 |
D/D |
594 |
14,074 |
2.31 |
- |
|
Parker Geoffrey M. |
Director |
|
2016-12-09 |
4 |
B |
$3.90 |
$2,318 |
D/D |
594 |
65,745 |
2.31 |
- |
|
Parker Geoffrey M. |
Director |
|
2016-12-08 |
4/A |
B |
$3.87 |
$12,159 |
D/D |
3,146 |
13,480 |
2.39 |
- |
|
Parker Geoffrey M. |
Director |
|
2016-12-08 |
4 |
B |
$3.87 |
$12,159 |
D/D |
3,146 |
65,151 |
2.39 |
- |
|
Parker Geoffrey M. |
Director |
|
2016-05-26 |
4 |
B |
$0.47 |
$4,455 |
D/D |
9,500 |
62,005 |
2.31 |
- |
|
Parker Geoffrey M. |
Director |
|
2016-05-25 |
4 |
B |
$0.49 |
$10,933 |
D/D |
22,505 |
52,505 |
2.39 |
- |
|
Parker Geoffrey M. |
Director |
|
2016-05-24 |
4 |
B |
$0.46 |
$13,881 |
D/D |
30,000 |
30,000 |
2.39 |
- |
|
Bjerkholt Eric |
EVP, CFO & Corp. Secretary |
|
2016-02-29 |
4 |
D |
$0.75 |
$26,243 |
D/D |
(34,991) |
100,922 |
|
- |
|
Bjerkholt Eric |
EVP, CFO & Corp. Secretary |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
135,913 |
|
- |
|
Swisher Daniel N Jr |
President and CEO |
|
2016-02-29 |
4 |
D |
$0.75 |
$41,756 |
D/D |
(55,675) |
266,519 |
|
- |
|
Swisher Daniel N Jr |
President and CEO |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
137,533 |
322,194 |
|
- |
|
Misfeldt Dayton |
Director |
|
2015-12-21 |
4 |
B |
$0.84 |
$1,470,000 |
I/I |
1,750,000 |
137,859 |
2.1 |
- |
|
Swisher Daniel N Jr |
President and CEO |
|
2015-08-25 |
4 |
B |
$1.01 |
$12,338 |
I/I |
12,216 |
199,736 |
2.58 |
- |
|
Swisher Daniel N Jr |
President and CEO |
|
2015-08-24 |
4 |
B |
$1.01 |
$12,912 |
I/I |
12,784 |
187,520 |
2.58 |
- |
|
Misfeldt Dayton |
Director |
|
2015-07-24 |
4 |
S |
$3.46 |
$2,200,242 |
I/I |
(635,702) |
105,134 |
|
- |
|
Misfeldt Dayton |
Director |
|
2015-07-24 |
4 |
OE |
$1.32 |
$2,198,896 |
I/I |
1,665,830 |
109,096 |
|
- |
|
Bjerkholt Eric |
EVP, CFO & Corp. Secretary |
|
2015-07-24 |
4 |
S |
$3.46 |
$21,989 |
I/I |
(6,358) |
83,827 |
|
- |
|
Bjerkholt Eric |
EVP, CFO & Corp. Secretary |
|
2015-07-24 |
4 |
OE |
$1.32 |
$21,986 |
I/I |
16,656 |
85,946 |
|
- |
|
Swisher Daniel N Jr |
President and CEO |
|
2015-07-24 |
4 |
B |
$1.02 |
$25,458 |
I/I |
25,000 |
174,336 |
2.66 |
- |
|
Swisher Daniel N Jr |
President and CEO |
|
2015-07-24 |
4 |
S |
$3.46 |
$43,975 |
I/I |
(12,715) |
149,736 |
|
- |
|
Swisher Daniel N Jr |
President and CEO |
|
2015-07-24 |
4 |
OE |
$1.32 |
$43,976 |
I/I |
33,315 |
153,974 |
|
- |
|
Ketchum Steven B |
Director |
|
2015-07-24 |
4 |
S |
$3.46 |
$21,989 |
D/D |
(6,358) |
84,259 |
|
- |
|
Ketchum Steven B |
Director |
|
2015-07-24 |
4 |
OE |
$1.32 |
$21,986 |
D/D |
16,656 |
86,378 |
|
- |
|
Bay City Capital Fund V Co-Investment Fund Lp |
10% Owner |
|
2015-07-24 |
4 |
S |
$3.46 |
$2,199,529 |
I/I |
(635,702) |
5,623,815 |
|
- |
|
162 Records found
|
|
Page 4 of 7 |
|
|